Medtronic (MDT) filed a complaint with the U.S. International Trade Commission, or ITC, along with a parallel action in U.S. District Court for the District of Delaware, to block Axonics (AXNX) from improperly importing and selling products that infringe two Medtronic patents related to the MRI compatibility of implantable medical devices. Medtronic is asking the ITC to investigate and exclude the importation of the infringing Axonics products into the U.S. Medtronic currently has a separate infringement suit pending in the U.S. District Court for the Central District of California in which it asserts that Axonics has infringed additional technologies developed by and belonging to Medtronic.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MDT:
- Orchestra BioMed presents new data on long-term effect of AVIM therapy
- Medtronic participates in a conference call with JPMorgan
- Medtronic price target raised to $90 from $87 at Truist
- Medtronic price target raised to $75 from $72 at UBS
- Medtronic price target raised to $98 from $95 at Mizuho
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue